249 related articles for article (PubMed ID: 23997051)
1. Drug-induced pulmonary arterial hypertension: a recent outbreak.
Montani D; Seferian A; Savale L; Simonneau G; Humbert M
Eur Respir Rev; 2013 Sep; 22(129):244-50. PubMed ID: 23997051
[TBL] [Abstract][Full Text] [Related]
2. Drugs induced pulmonary arterial hypertension.
Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced pulmonary arterial hypertension: a review.
Garg L; Akbar G; Agrawal S; Agarwal M; Khaddour L; Handa R; Garg A; Shah M; Patel B; Dalal BD
Heart Fail Rev; 2017 May; 22(3):289-297. PubMed ID: 28417295
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension.
Toya T; Nagatomo Y; Kagami K; Yukino M; Yasuda R; Namba T; Ido Y; Kobayashi S; Masaki N; Yada H; Kimura F; Adachi T
Int J Cardiovasc Imaging; 2019 Aug; 35(8):1435-1442. PubMed ID: 30715668
[TBL] [Abstract][Full Text] [Related]
5. Drug-associated pulmonary arterial hypertension.
McGee M; Whitehead N; Martin J; Collins N
Clin Toxicol (Phila); 2018 Sep; 56(9):801-809. PubMed ID: 29508628
[TBL] [Abstract][Full Text] [Related]
6. A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation.
Ko T; Hatano M; Nitta D; Muraoka H; Minatsuki S; Imamura T; Inaba T; Maki H; Yao A; Kinugawa K; Komuro I
Heart Vessels; 2016 Jul; 31(7):1206-8. PubMed ID: 26081027
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension-"state of the art" management in 2012.
Saxena A
Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428
[TBL] [Abstract][Full Text] [Related]
8. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.
Baumgart B; Guha M; Hennan J; Li J; Woicke J; Simic D; Graziano M; Wallis N; Sanderson T; Bunch RT
Cancer Chemother Pharmacol; 2017 Apr; 79(4):711-723. PubMed ID: 28283735
[TBL] [Abstract][Full Text] [Related]
10. The Role of Sex in the Pathophysiology of Pulmonary Hypertension.
Docherty CK; Harvey KY; Mair KM; Griffin S; Denver N; MacLean MR
Adv Exp Med Biol; 2018; 1065():511-528. PubMed ID: 30051404
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
[TBL] [Abstract][Full Text] [Related]
12. Serotonin Signaling Through the 5-HT
Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
[TBL] [Abstract][Full Text] [Related]
13. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib-induced pulmonary arterial hypertension.
Özgür Yurttaş N; Eşkazan AE
Br J Clin Pharmacol; 2018 May; 84(5):835-845. PubMed ID: 29334406
[TBL] [Abstract][Full Text] [Related]
16. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?
Seferian A; Simonneau G
Eur Respir Rev; 2013 Sep; 22(129):217-26. PubMed ID: 23997048
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
Kylhammar D; Persson L; Hesselstrand R; Rådegran G
Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
[TBL] [Abstract][Full Text] [Related]
18. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M
Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190
[TBL] [Abstract][Full Text] [Related]
19. A critical analysis of survival in pulmonary arterial hypertension.
O'Callaghan DS; Humbert M
Eur Respir Rev; 2012 Sep; 21(125):218-22. PubMed ID: 22941886
[TBL] [Abstract][Full Text] [Related]
20. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]